We recently wrote about a new, growing type of cancer center focused on immunotherapy and collaboration between top doctors. Our Actos attorneys are happy to report that a new immunotherapy drug, Tecentriq, has been approved to treat bladder cancer. As our Actos bladder cancer clients know, there have not been any important improvements in bladder …
Actos Plaintiffs Consider $2.4 Billion Settlement
Actos’ manufacturer, Takeda Pharmaceuticals, recently agreed to pay $2.37 billion to resolve the majority of bladder cancer lawsuits. Our team of Actos attorneys is pleased to announce this potential settlement to our Actos bladder cancer clients. Takeda Pharmaceuticals is Asia’s largest drugmaker and will continue to sell Actos in the U.S., Japan and other countries after litigation resolves. Several …
$3.6 Million Verdict for Actos Bladder Cancer
A Philadelphia jury recently awarded $2.3 million to a man who developed bladder cancer and had to have his bladder removed from taking the drug Actos. Actos is prescribed to type 2 diabetics and has been subject to massive litigation and billion-dollar verdicts. Actos attorneys at Pintas & Mullins Law Firm detail this most recent case. The …
Actos Bladder Cancer Lawsuit Begins Today
A plaintiff diagnosed with bladder cancer after taking the drug Actos will have his chance in court beginning today, Monday October 20th. This will be the first Actos trial in West Virginia over allegations that the diabetes drug causes bladder cancer. Actos attorneys at Pintas & Mullins Law Firm detail this case and others like it around …
Study Suggests Actos Could Affect Alzheimer’s Risk
Actos attorneys at Pintas & Mullins Law Firm highlight several recent studies focusing on Alzheimer’s risk and methods of preventing the disease. Nursing home residents with Alzheimer’s and other forms of dementia are significantly more likely to be victims of abuse and neglect, so families need to have all information on-hand to prevent such mistreatment. The …
Actos Manufacturer Guilty of Destroying Evidence
Actos attorneys at Pintas & Mullins Law Firm recently reported that the jury in the first bellwether lawsuit decided to award plaintiffs injured by the diabetes drug Actos $9 billion. In addition to this immense award, the judge in the case also found that Takeda Pharmaceuticals (which marketed Actos along with Eli Lilly) was guilty of intentionally …
Actos Plaintiff Receives $9 Billion Jury Award
The jury is out, and the manufacturers of Actos, the once-popular type 2 diabetes medication, are now ordered to pay $9 billion (yes, with a ‘b’) to a man who developed bladder cancer from the medication. The award is the seventh-largest in U.S. history, and there thousands more Actos cases still to be heard. Actos attorneys at …
The Link Between Diabetes Medicines and Cancer
Millions of Americans – over 8% of the population – have diabetes, the majority of which is type 2 diabetes. This makes the drug market for this condition extremely attractive and profitable to pharmaceutical companies around the world. Unfortunately, in its haste to develop new and better diabetic medications, Big Pharma is not testing these …
Actos Bladder Cancer Lawsuits Update
The recent litigation over Takeda Pharmaceuticals diabetes drug Actos (pioglitazone) has taken a significant turn recently, after a federal judge ruled the company breached its duty to preserve evidence in the Actos multi-district litigation (MDL). The MDL, based in Louisiana, focuses on claims that the medication caused bladder cancer in diabetic patients. Actos attorneys at Pintas & …
FDA Loosens Avandia Prescribing Restrictions Despite Risks
In a strange move, the FDA recently removed several restrictions for the prescribing of a popular and dangerous diabetes drug known as Avandia. After a 2007 study linked the drug to increased risk of heart attacks, Avandia was largely discredited and sales curtailed significantly in the U.S., much to the dismay of its manufacturer, GlaxoSmithKline. …
Family Awarded $1.7 Million for Actos Bladder Cancer Death
Actos attorneys at Pintas & Mullins Law Firm report on the latest from the Actos litigation currently playing out in Maryland against Takeda Pharmaceuticals; the plaintiffs in this case, the family of a deceased Actos patient, was initially awarded $1.7 million. The jury also found, however, that the man contributed to his own death, likely by …
First Actos Plaintiff Awarded $6.5 Million
Actos attorneys at Pintas & Mullins Law Firm report that a California jury recently awarded $6.5 million to a man who sued Takeda Pharmaceutics after he developed bladder cancer. This is one of more than 3,000 similar Actos cases currently pending in the United States. The plaintiff in this case, Jack Cooper, obtained an early trial date because …
Drug Recall Replacement for Actos Delayed
Takeda Pharmaceutical, the manufacturer of Alogliptin, received more discouraging news from the United States Food and Drug Administration (FDA). The FDA mandated that Takeda provide more information regarding the safety of Alogliptin, declining to approve the much-needed drug for the second time. Alogliptin was created to replace the dangerous and heavily litigated Actos. Our Illinois drug …
Actos Drug’s Link to Bladder Cancer Concerns
The U.S. Food and Drug Administration, along with government agencies in several European countries, are warning about the increased risk for bladder cancer for patients using Actos to treat type 2 diabetes. Drug regulators worldwide are taking steps to protect the health and safety of Actos users and prevent further harm. Unfortunately, in many cases, …